Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.41 -0.08 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Camp4 Therapeutics (CAMP) Interest Coverage Ratio (2023 - 2024)

Camp4 Therapeutics (CAMP) posted Interest Coverage Ratio of 233.41 for Q1 2026, down 4475.54% sequentially from 5.33 in Q4 2025, and down 1924.08% YoY from 12.8 in Q1 2025.

Analysis

Camp4 Therapeutics (CAMP) Interest Coverage Ratio (2023 - 2024) Analysis & Trends

Camp4 Therapeutics has reported Interest Coverage Ratio for 4 years, with the latest figure at 233.41 in Q1 2026.

  • Quarterly Interest Coverage Ratio fell 1924.08% year-over-year to 233.41 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 160.63 (up 220.22% YoY) and the FY2025 annual result came in at 0.69, up 15.59% from the prior year.
  • Interest Coverage Ratio slipped to 233.41 in Q1 2026 per CAMP's latest filing, from 5.33 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 5.64 in Q4 2024 and troughed at 233.41 in Q1 2026.
  • A 4-year average of 42.04 and a median of 11.67 in 2024 frame the typical range for Interest Coverage Ratio.
  • The sharpest annual moves came in 2024 and 2026: Interest Coverage Ratio jumped 103.47% in 2024, then sank 1924.08% in 2026.
  • Over 4 years, Interest Coverage Ratio stood at 162.36 in 2023, then soared by 103.47% to 5.64 in 2024, then decreased by 5.35% to 5.33 in 2025, then plunged by 4475.54% to 233.41 in 2026.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods registered 233.41, 5.33, and 15.58 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Camp4 Therapeutics 260.10 Mn 260.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 96.79
Sep 30, 2024 -218.00
Dec 31, 2023 -162.36
Sep 30, 2023 -262.51